Ability of Rotator Cuff Muscle Strength Levels, Assessed by Isokinetic Dynamometry, to Predict Return to Sport After Shoulder Stabilization Surgery by Open Latarjet Procedure

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorRamsay Générale de Santé

About this trial

The stabilization surgical treatment by open Latarjet procedure is one of the reference treatments after anterior glenohumeral dislocation in athletes. This surgical technique allows low recurrence rates and high return to sport rates. Indeed, more than 90% of athletes return to sport after this type of surgery, but only 60% are able to resume the same activity as a preinjury level of performance. Therefore, adaptations in the postoperative management of athletes patients seem necessary. Isokinetic dynamometry is considered the gold standard to provide an objective assessment of muscle strength abilities, particularly in the clinical setting. Although rehabilitation exercises are prescribed early after the Latarjet procedure, muscle deconditioning occurs during the postoperative phase, limiting the abilities of the rotator cuff muscles to provide stability to the glenohumeral joint. Therefore, recovery of all components of strength, i.e. maximal strength, power, and strength endurance of the rotator cuff muscles appears crucial for the athletes to return to their sport at the pre-injury level. However, at present, the strength levels to be recovered remain to be defined.

Eligibility criteria

Qualifiers

Be aged between 18 and 45

Occurrence of the injury during the practice of a sporting activity

Post-traumatic anterior glenohumeral subluxation/dislocation

Contralateral shoulder with no history of injury

Disqualifiers

Contraindication from the sports clinician or surgeon

Have another pathology in the upper limbs.

Have constitutional hyperlaxity

Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

Trial design

Treatments tested in this trial

  • Questionnaires
  • Exercices

Treatment groups

210 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ramsay Générale de Santé

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche

Collaborator